通过调制ESM1-MAPK/ERK信号轴,CuET抑制了Ewing肉瘤骨的进展
Wantong Xu1, Zhongbiao Jiang2, Dan Peng1
1Department of Orthopaedic Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
International immunopharmacology
|March 6, 2026
概括
铜二甲基二甲基碳酸盐 (CuET) 与其组成部分相比,在对抗骨Ewing肉瘤方面表现出优异的抗瘤作用. 向ESM1-MAPK/ERK通路可以提高CuET的疗效,为这种罕见的骨癌提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 尤文肉瘤是儿童和青少年罕见的骨癌,复发/转移性疾病的预后不佳.
- 铜二甲基二甲基碳酸盐 (CuET),是迪苏尔菲拉姆的代谢物,显示出潜在的抗瘤活性,但其在尤文肉瘤中的作用尚不清楚.
研究的目的:
- 为了研究CuET在骨Ewing肉瘤中的抗瘤功效和机制.
- 确定参与CuET治疗效果和耐药性的生物标志物和信号通路.
主要方法:
- 在细胞系和异种移植中比较CuET,二甲基二甲基酸盐 (DDTC) 和铜离子 (Cu2+).
- 利用RNA-seq,西部斑块和生物信息学来识别ESM1作为生物标志物.
- 验证了ESM1的功能,并研究了MAPK/ERK通路的参与.
主要成果:
- 与单独使用DDTC或Cu2+相比,CuET的抗瘤疗效显著更大.
- 确定ESM1是一个关键的调节器,促进了扩散和CuET耐药性.
- 证实了MAPK/ERK通路是ESM1驱动瘤攻击性和抗性的机制.
结论:
- CuET对尤文肉瘤具有增强的抗瘤活性.
- 通过MAPK/ERK通路,ESM1调节了肉瘤的扩散和CuET抵抗.
- 针对ESM1-MAPK/ERK轴协同改善CuET的治疗效果,建议新的治疗策略.
相关概念视频
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Mitogens and the Cell Cycle
8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.8K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
MAPK Signaling Cascades
8.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K
Interactions Between Signaling Pathways
7.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K


